Latest filing published 13 Jul 2026 for PTC Therapeutics, INC., €376k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Mary L. Smith: trading record in brief
Mary L. Smith (board member) discloses dealings in PTC Therapeutics, Inc. to SEC (Form 4). We count 11 filings; the first trade dates from 11 June 2021 and the latest from 9 July 2026.
On the market, this insider has only sold: 2 sales, €1.2M in total. Outside the open market, there are 7 share grants and 2 option exercises. 2026 to date brings no purchases and 2 sales.
On 13 July 2026 came the latest disclosure, an option exercise for €376k in PTC Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mary L. Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$42.950.0061% mcap12.2% of flowCommon StockSEC:0001866044-26-000005:0
- 10,000 shares@ US$90.000.013% mcap25.5% of flowCommon StockSEC:0001866044-26-000005:1
- 5,834 shares@ US$42.950.0035% mcap7.1% of flowCommon StockSEC:0001866044-26-000005:2
- 5,834 shares@ US$90.000.0074% mcap14.9% of flowCommon StockSEC:0001866044-26-000005:3
- 4,000 shares0Common StockSEC:0001866044-26-000003:0
- 4,000 shares0Common StockSEC:0001415889-25-001026:0
- 4,000 shares0Common StockSEC:0001415889-24-004098:0
- 4,000 shares0Common StockSEC:0001415889-23-000668:0
- 3,200 shares0Common StockSEC:0001179110-22-000393:0
- 1,650 shares0Common StockSEC:0001179110-21-006723:0
10 of 10 declarations
